Related Experiment Videos
Technetium-99m-sestamibi uptake by recurrent Hurthle cell carcinoma of the thyroid
H R Balon1, D Fink-BennetT, S S Stoffer
1Nuclear Medicine Department, William Beaumont Hospital, Royal Oak, Michigan 48073-6769.
Abstract:
Technetium-99m-sestamibi has been reported to localize in various tumors. Scintigraphic results for a patient with recurrent Hurthle cell carcinoma of the thyroid whose tumor was imaged with both 99mTc-sestamibi and 201TI, but not with 131I, are presented.